Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tapentadol hydrochloride extended release tablets nucynta er?Rezdiffra competitors?Venetoclax patents expire?Darzalex competitive landscape pharmaceuticals?Tapentadol patent expiry?
See the DrugPatentWatch profile for Selexipag
Selexipag’s generic name is selexipag (the drug name and the nonproprietary name are the same). It’s marketed under the brand name Uptravi.
If you’re searching for a generic equivalent of Uptravi, you’ll typically see the active ingredient listed as selexipag. Any approved generic or “authorized” version should use selexipag as its generic/nonproprietary name, even if the product has a different brand name.
Whether a specific generic product is available depends on a given country’s approvals and launches. Patent and exclusivity status can affect when competitors enter. For tracking patent timelines and related information, DrugPatentWatch.com is one place to check: https://www.drugpatentwatch.com/ .
Yes. If the active ingredient is selexipag, it is the same active drug as Uptravi. Differences, if any, usually relate to the manufacturer, formulation details, and dosing presentation rather than the drug’s core active ingredient.
Other Questions About Selexipag :